T-cell immune responses in the brain and their relevance for cerebral malignanciesWALKER, Paul R; CALZASCIA, Thomas; DE TRIBOLET, Nicolas et al.Brain research reviews. 2003, Vol 42, Num 2, pp 97-122, issn 0165-0173, 26 p.Article

Lymphome et prurit : une association parfois parasitée : Cancer = Lymphoma and pruritis : search for parasitesGETAZ, Laurent; GETAZ, Laurent et al.MEZGER, Nathalie; GETAZ, Laurent; GETAZ, Laurent et al.Revue médicale suisse. 2009, Vol 5, Num 204, pp 1112-1114, issn 1660-9379, 3 p.Article

Limits of CD133 as a marker of glioma self-renewing cellsCLEMENT, Virginie; DUTOIT, Valérie; MARINO, Denis et al.International journal of cancer (Print). 2009, Vol 125, Num 1, pp 244-248, issn 0020-7136, 5 p.Article

Cytomegalovirus colitis: A severe complication after standard chemotherapyMATTHES, Thomas; KAISER, Laurent; WEBER, Damien et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 704-706, issn 0284-186X, 3 p.Article

Stem Cell-Related Self-Renewal Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in GlioblastomaMURAT, Anastasia; MIGLIAVACCA, Eugenia; HAINFELLNER, Johannes A et al.Journal of clinical oncology. 2008, Vol 26, Num 18, pp 3015-3024, issn 0732-183X, 10 p.Article

Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8⁺ T-cell responses to the tumor-specific antigen NY-ESO-1LE GAL, Frédérique-Anne; AYYOUB, Maha; DUTOIT, Valérie et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 3, pp 252-257, issn 1524-9557, 6 p.Article

Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma. CommentaryHEIMBERGER, Amy B; ARCHER, Gary E; RUTKA, James T et al.Neurosurgery. 2002, Vol 50, Num 1, pp 158-166, issn 0148-396XArticle

Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1CONTASSOT, Emmanuel; WILMOTTE, Rick; TENAN, Mirna et al.Journal of neuropathology and experimental neurology. 2004, Vol 63, Num 9, pp 956-963, issn 0022-3069, 8 p.Article

Direct transoral approach to C2 for percutaneous vertebroplastyMARTIN, Jean-Baptiste; GAILLOUD, Philippe; DIETRICH, Pierre-Yves et al.Cardiovascular and interventional radiology (Print). 2002, Vol 25, Num 6, pp 517-519, issn 0174-1551, 3 p.Article

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell CarcinomaALBIGES, Laurence; OUDARD, Stéphane; LAGUERRE, Brigitte et al.Journal of clinical oncology. 2012, Vol 30, Num 5, pp 482-487, issn 0732-183X, 6 p.Article

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomideHEGI, Monika E; DISERENS, Annie-Claire; GODARD, Sophie et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 1871-1874, issn 1078-0432, 4 p.Article

Circulating tumor-reactive CD8⁺ T cells in melanoma patients contain a CD45RA⁺CCR7^- effector subset exerting ex vivo tumor-specific cytolytic activityVALMORI, Danila; SCHEIBENBOGEN, Carmen; LIPP, Martin et al.Cancer research (Baltimore). 2002, Vol 62, Num 6, pp 1743-1750, issn 0008-5472Article

Heterogeneous T-cell response to MAGE-A10_254-262: High avidity-specific cytolytic T lymphocytes show superior antitumor activityDUTOIT, Valérie; RUBIO-GODOY, Verena; CEROTTINI, Jean-Charles et al.Cancer research (Baltimore). 2001, Vol 61, Num 15, pp 5850-5856, issn 0008-5472Article

Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98MARTINELLI, Giovanni; HSU SCHMITZ, Shu-Fang; VOROBIOF, Daniel et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4480-4484, issn 0732-183X, 5 p.Article

Vaccination of Melanoma Patients With Melan-A/Mart-1 Peptide and Klebsiella Outer Membrane Protein P40 as an AdjuvantLIENARD, Danielle; AVRIL, Marie-Françoise; DIETRICH, Pierre-Yves et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 8, pp 875-883, issn 1524-9557, 9 p.Article

Anticorps et tumeurs solides: Cibles établies et pistes prometteuses = The potential of monoclonal antibodies in cancer: established trastuzumab and cetuximab and promising targets IGF-1R and c-METBODMER, Alexandre; GOETSCH, Liliane; FAVET, Laurence et al.MS. Médecine sciences. 2009, Vol 25, Num 12, pp 1090-1098, issn 0767-0974, 9 p.Article

Tissue homing and persistence of defined antigen-specific CD8⁺ tumor-reactive T-cell clones in long-term melanoma survivorsLE GAL, Frédérique-Anne; WIDMER, Valérie M; DUTOIT, Valérie et al.Journal of investigative dermatology. 2007, Vol 127, Num 3, pp 622-629, issn 0022-202X, 8 p.Article

Recommandations pour la prise en charge du mélanome = Melanoma clinical managementGUGGISBERG, David; CEROTTINI, Jean-Philippe; KRISCHER, Joachim et al.Revue médicale de la Suisse romande. 2002, Vol 122, Num 1, pp 5-8, issn 0035-3655Article

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaROMERO, Pedro; VALMORI, Danila; GUILLAUME, Philippe et al.Immunological reviews. 2002, Vol 188, pp 81-96, issn 0105-2896, 16 p.Article